Therapy in cancer 2008 quo vadis? /
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Video |
| Language: | English |
| Published: |
London :
Henry Stewart Talks,
2009.
|
| Series: | Henry Stewart talks. Biomedical & life sciences collection. Cancer therapy : latest thinking in efficacy and toxicity.
|
| Subjects: | |
| Online Access: | https://hstalks.com/bs/1112/ Series |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Add Tag
Table of Contents:
- Contents: Why pursuing new therapeutic approaches in cancer is important
- Prevention and screening
- Current cancer therapy: non-surgical
- Most chemotherapy targets DNA
- Chemotherapy effects
- Current state of cancer therapy: efficacy and toxicity
- Molecular pathogenesis of cancer
- Pursuing targeted therapy in cancers
- Targeted biologic therapies
- Evolving targets and agents
- Shift from chemotherapy to targeted agents
- Clinically established molecular targets in malignancies
- Targeted therapy: proteins and small molecules
- Changes brought about by targeting: efficacy and toxicity
- Biomarkers in drug development
- What is currently known: angiogenesis
- The VEGF family and its receptors
- Bevacizumab and Sorafenib
- Does toxicity correlate with response?
- What research is ongoing: agents?
- Future directions in cancer treatment options
- Core pathways altered in pancreatic and colorectal cancer.
Therapy in cancer 2008 quo vadis? /